Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImmTher with Chemotherapy in High Risk Ewing's Sarcoma
NCT00003667Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 1998
- Primary completion
- Aug 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Disaccharide tripeptide glycerol dipalmitoyl in Ewing sarcoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 1998; status: completed.
02
Drugs
Disaccharide tripeptide glycerol dipalmitoyl
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT00003667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003667.